Skip to main content
Premium Trial:

Request an Annual Quote

Israel's Teva and Procognia to Collaborate on Biopharmaceuticals

NEW YORK (GenomeWeb News) – Teva Pharmaceutical Industries and the Israeli subsidiary of protein array company Procognia will collaborate on two biopharmaceutical products, the companies said today.
 
Under the agreement, Teva will have exclusive access to Procognia Israel’s glycoanalysis technology and related services.
 
Procognia will receive milestone and royalty payments from Teva, which will finance the collaboration.
 
Additional financial details were not disclosed.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.